Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
View graph of relations


Asthma; translational research; airway inflammation; biological treatment; airway hyperresponsiveness

Main research areas

Asthma epidemiology; asthma diagnostics; airway inflammation; airway hyperresponsiveness; airway immunology

Current research

Currently running a investigator-initiated phase IIa study called UPSTREAM that examines the effects of blocking the immunopathway driven by TSLP in asthma. The study is a double-blind, randomized, placebo-controlled trial of Tezepelumab (anti-TSLP) in subjects with symptomatic asthma despite treatment with inhaled corticosteroids.

Potential conflicts of interest

Participation in international medical congresses sponsored by pharma companies: Astra Zeneca, Sandoz

ID: 31009910